{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:11:21Z","timestamp":1790802681256,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T00:00:00Z","timestamp":1617840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T00:00:00Z","timestamp":1617840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["22647"],"award-info":[{"award-number":["22647"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Despite improvements in median survival some patients with advanced ovarian cancer die within 100\u2009days of diagnosis; the reasons for which remain poorly understood.<\/jats:p>\n                <jats:p>Here we investigate if ultra short-term survival can be explained by patient characteristics or treatment pathways.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A nested case comparison study was used to examine differences between patients with high grade serous ovarian\/fallopian tube cancer who died within 100\u2009days (<jats:italic>n<\/jats:italic>\u00a0=\u200928) compared to a comparison group of patients matched for histology and including any survival greater than 100\u2009days (<jats:italic>n<\/jats:italic>\u00a0=\u2009134).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Cases and comparison patients had similar ages, BMI, ACE-27, deprivation indices, and distribution of disease on CT. There were no significant delays in time to diagnosis or treatment (<jats:italic>p<\/jats:italic>\u00a0=\u20090.68) between the groups.<\/jats:p>\n                <jats:p>However, cases had lower serum albumin, haemoglobin and higher platelet counts than matched comparison patients (<jats:italic>p<\/jats:italic>\u00a0&lt;\u20090.0001) and a worse performance score (<jats:italic>P<\/jats:italic>\u00a0=\u20090.006).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Patients who die rapidly after a diagnosis of ovarian cancer are only slightly older and have similar pre treatment frailty compared to patients whose survival approaches the median. However they do appear to undergo greater physiological compromise as a result of their disease.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-021-08019-9","type":"journal-article","created":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T13:03:17Z","timestamp":1617886997000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Factors determining ultra-short-term survival and the commencement of active treatment in high-grade serous ovarian cancer: a case comparison study"],"prefix":"10.1186","volume":"21","author":[{"given":"Amy","family":"Hawarden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryn","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Ellen","family":"Gee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Kayali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Clamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma Jayne","family":"Crosbie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2553-4423","authenticated-orcid":false,"given":"Richard John","family":"Edmondson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,8]]},"reference":[{"issue":"11","key":"8019_CR1","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/nrc4019","volume":"15","author":"DD Bowtell","year":"2015","unstructured":"Bowtell DD, B\u00f6hm S, Ahmed AA, Aspuria PJ, Bast RC Jr, Beral V, Berek JS, Birrer MJ, Blagden S, Bookman MA, Brenton JD, Chiappinelli KB, Martins FC, Coukos G, Drapkin R, Edmondson R, Fotopoulou C, Gabra H, Galon J, Gourley C, Heong V, Huntsman DG, Iwanicki M, Karlan BY, Kaye A, Lengyel E, Levine DA, Lu KH, McNeish IA, Menon U, Narod SA, Nelson BH, Nephew KP, Pharoah P, Powell DJ Jr, Ramos P, Romero IL, Scott CL, Sood AK, Stronach EA, Balkwill FR. Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer. Nat Rev Cancer. 2015;15(11):668\u201379. https:\/\/doi.org\/10.1038\/nrc4019.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"8019_CR2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13073-018-0590-x","volume":"10","author":"SYC Yang","year":"2018","unstructured":"Yang SYC, Lheureux S, Karakasis K, Burnier JV, Bruce JP, Clouthier DL, Danesh A, Quevedo R, Dowar M, Hanna Y, Li T, Lu L, Xu W, Clarke BA, Ohashi PS, Shaw PA, Pugh TJ, Oza AM. Landscape of genomic alterations in high-grade serous ovarian cancer from exceptional long- and short-term survivors. Genome Med. 2018;10(1):81. https:\/\/doi.org\/10.1186\/s13073-018-0590-x.","journal-title":"Genome Med"},{"key":"8019_CR3","unstructured":"NCIN, Short term ovarian cancer mortality, http:\/\/www.ncin.org.uk\/publications\/data_briefings\/short_term_ovarian_cance and r.m. . Editors. cited 2018."},{"issue":"3","key":"8019_CR4","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.ygyno.2015.12.021","volume":"140","author":"RR Urban","year":"2016","unstructured":"Urban RR, He H, Alfonso R, Hardesty MM, Gray HJ, Goff BA. Ovarian cancer outcomes: predictors of early death. Gynecol Oncol. 2016;140(3):474\u201380. https:\/\/doi.org\/10.1016\/j.ygyno.2015.12.021.","journal-title":"Gynecol Oncol"},{"key":"8019_CR5","unstructured":"Macnab, W.a.G.R.a.S.S.a.S.A.H.a.B.K.A.a.M.I.a.R.N.S.a.S.N.a., Outcomes of women not receiving treatment for advanced ovarian cancer in the West of Scotland: A retrospective analysis. 2018. 39: p. 58\u201362."},{"key":"8019_CR6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ejogrb.2017.04.016","volume":"213","author":"C Fotopoulou","year":"2017","unstructured":"Fotopoulou C, Hall M, Cruickshank D, Gabra H, Ganesan R, Hughes C, Kehoe S, Ledermann J, Morrison J, Naik R, Rolland P, Sundar S. British Gynaecological Cancer society (BGCS) epithelial ovarian\/fallopian tube\/primary peritoneal cancer guidelines: recommendations for practice. Eur J Obstet Gynecol Reprod Biol. 2017;213:123\u201339. https:\/\/doi.org\/10.1016\/j.ejogrb.2017.04.016.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"8019_CR7","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jamcollsurg.2014.01.059","volume":"219","author":"D Kallogjeri","year":"2014","unstructured":"Kallogjeri D, Gaynor SM, Piccirillo ML, Jean RA, Spitznagel EL Jr, Piccirillo JF. Comparison of comorbidity collection methods. J Am Coll Surg. 2014;219(2):245\u201355. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2014.01.059.","journal-title":"J Am Coll Surg"},{"key":"8019_CR8","volume-title":"Ministry of housing","author":"Ministry of housing, c.a.l.G","year":"2015","unstructured":"Ministry of housing, c.a.l.G. English Indices of deprivation 2015, c.a.l.G. In: Ministry of housing. UK: GOV; 2015."},{"issue":"1","key":"8019_CR9","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/AOG.0000000000000917","volume":"126","author":"J Prat","year":"2015","unstructured":"Prat J. Staging classification for Cancer of the ovary, fallopian tube, and peritoneum: abridged republication of guidelines from the International Federation of Gynecology and Obstetrics (FIGO). Obstet Gynecol. 2015;126(1):171\u20134. https:\/\/doi.org\/10.1097\/AOG.0000000000000917.","journal-title":"Obstet Gynecol"},{"issue":"6","key":"8019_CR10","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1177\/0269216314568231","volume":"29","author":"J Su","year":"2015","unstructured":"Su J, Barbera L, Sutradhar R. Do repeated assessments of performance status improve predictions for risk of death among patients with cancer? A population-based cohort study. Palliat Med. 2015;29(6):547\u201353. https:\/\/doi.org\/10.1177\/0269216314568231.","journal-title":"Palliat Med"},{"issue":"4","key":"8019_CR11","first-page":"328","volume":"28","author":"BAADL V\u00e1s\u00e1rhelyi","year":"2017","unstructured":"V\u00e1s\u00e1rhelyi BAADL. Lab test findings in the elderly. Ejifcc. 2017;28(4):328\u201332.","journal-title":"Ejifcc"},{"issue":"3","key":"8019_CR12","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1097\/IGC.0000000000000368","volume":"25","author":"MJ Rutten","year":"2015","unstructured":"Rutten MJ, van de Vrie R, Bruining A, Spijkerboer AM, Mol BW, Kenter GG, Buist MR. Predicting surgical outcome in patients with International Federation of Gynecology and Obstetrics stage III or IV ovarian cancer using computed tomography: a systematic review of prediction models. Int J Gynecol Cancer. 2015;25(3):407\u201315. https:\/\/doi.org\/10.1097\/IGC.0000000000000368.","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"8019_CR13","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1177\/0284185116658683","volume":"58","author":"HM Son","year":"2017","unstructured":"Son HM, Kim SH, Kwon BR, Kim MJ, Kim CS, Cho SH. Preoperative prediction of suboptimal resection in advanced ovarian cancer based on clinical and CT parameters. Acta Radiol. 2017;58(4):498\u2013504. https:\/\/doi.org\/10.1177\/0284185116658683.","journal-title":"Acta Radiol"},{"issue":"1","key":"8019_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ygyno.2017.02.020","volume":"145","author":"RS Suidan","year":"2017","unstructured":"Suidan RS, Ramirez PT, Sarasohn DM, Teitcher JB, Iyer RB, Zhou Q, Iasonos A, Denesopolis J, Zivanovic O, Long Roche KC, Sonoda Y, Coleman RL, Abu-Rustum NR, Hricak H, Chi DS. A multicenter assessment of the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease at primary debulking for advanced epithelial ovarian cancer. Gynecol Oncol. 2017;145(1):27\u201331. https:\/\/doi.org\/10.1016\/j.ygyno.2017.02.020.","journal-title":"Gynecol Oncol"},{"issue":"11","key":"8019_CR15","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1093\/jnci\/djt065","volume":"105","author":"RE Bristow","year":"2013","unstructured":"Bristow RE, Powell MA, al-Hammadi N, Chen L, Miller JP, Roland PY, Mutch DG, Cliby WA. Disparities in ovarian cancer care quality and survival according to race and socioeconomic status. J Natl Cancer Inst. 2013;105(11):823\u201332. https:\/\/doi.org\/10.1093\/jnci\/djt065.","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"8019_CR16","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.ygyno.2015.09.015","volume":"139","author":"VB Galvan-Turner","year":"2015","unstructured":"Galvan-Turner VB, Chang J, Ziogas A, Bristow RE. Observed-to-expected ratio for adherence to treatment guidelines as a quality of care indicator for ovarian cancer. Gynecol Oncol. 2015;139(3):495\u20139. https:\/\/doi.org\/10.1016\/j.ygyno.2015.09.015.","journal-title":"Gynecol Oncol"},{"issue":"14","key":"8019_CR17","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.7150\/jca.30335","volume":"10","author":"C Zhang","year":"2019","unstructured":"Zhang C, Guo X, Peltzer K, Ma W, Qi L, Zhang Y, Han X, Baklaushev VP, Yao Y, Wang G, Chekhonin VP, Wang X, Ma Y. The prevalence, associated factors for bone metastases development and prognosis in newly diagnosed ovarian cancer: a large population based real-world study. J Cancer. 2019;10(14):3133\u20139. https:\/\/doi.org\/10.7150\/jca.30335.","journal-title":"J Cancer"},{"key":"8019_CR18","doi-asserted-by":"crossref","unstructured":"TCGA, Integrated genomic analyses of ovarian carcinoma. Nature. 2011;474(7353):609\u201315.","DOI":"10.1038\/nature10166"},{"issue":"22","key":"8019_CR19","doi-asserted-by":"publisher","first-page":"5675","DOI":"10.1158\/0008-5472.CAN-12-0324","volume":"72","author":"A Mukhopadhyay","year":"2012","unstructured":"Mukhopadhyay A, Plummer ER, Elattar A, Soohoo S, Uzir B, Quinn JE, McCluggage WG, Maxwell P, Aneke H, Curtin NJ, Edmondson RJ. Clinicopathological features of homologous recombination-deficient epithelial ovarian cancers: sensitivity to PARP inhibitors, platinum, and survival. Cancer Res. 2012;72(22):5675\u201382. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-0324.","journal-title":"Cancer Res"},{"issue":"16","key":"8019_CR20","doi-asserted-by":"publisher","first-page":"5198","DOI":"10.1158\/1078-0432.CCR-08-0196","volume":"14","author":"RW Tothill","year":"2008","unstructured":"Tothill RW, Tinker AV, George J, Brown R, Fox SB, Lade S, Johnson DS, Trivett MK, Etemadmoghadam D, Locandro B, Traficante N, Fereday S, Hung JA, Chiew YE, Haviv I, Australian Ovarian Cancer Study Group, Gertig D, deFazio A, Bowtell DDL. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Clin Cancer Res. 2008;14(16):5198\u2013208. https:\/\/doi.org\/10.1158\/1078-0432.CCR-08-0196.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"8019_CR21","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1038\/s41588-018-0179-8","volume":"50","author":"G Macintyre","year":"2018","unstructured":"Macintyre G, Goranova TE, de Silva D, Ennis D, Piskorz AM, Eldridge M, Sie D, Lewsley LA, Hanif A, Wilson C, Dowson S, Glasspool RM, Lockley M, Brockbank E, Montes A, Walther A, Sundar S, Edmondson R, Hall GD, Clamp A, Gourley C, Hall M, Fotopoulou C, Gabra H, Paul J, Supernat A, Millan D, Hoyle A, Bryson G, Nourse C, Mincarelli L, Sanchez LN, Ylstra B, Jimenez-Linan M, Moore L, Hofmann O, Markowetz F, McNeish IA, Brenton JD. Copy number signatures and mutational processes in ovarian carcinoma. Nat Genet. 2018;50(9):1262\u201370. https:\/\/doi.org\/10.1038\/s41588-018-0179-8.","journal-title":"Nat Genet"},{"issue":"3","key":"8019_CR22","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1158\/2159-8290.CD-17-0284","volume":"8","author":"OMT Pearce","year":"2018","unstructured":"Pearce OMT, Delaine-Smith RM, Maniati E, Nichols S, Wang J, B\u00f6hm S, Rajeeve V, Ullah D, Chakravarty P, Jones RR, Montfort A, Dowe T, Gribben J, Jones JL, Kocher HM, Serody JS, Vincent BG, Connelly J, Brenton JD, Chelala C, Cutillas PR, Lockley M, Bessant C, Knight MM, Balkwill FR. Deconstruction of a metastatic tumor microenvironment reveals a common matrix response in human cancers. Cancer Discov. 2018;8(3):304\u201319. https:\/\/doi.org\/10.1158\/2159-8290.CD-17-0284.","journal-title":"Cancer Discov"}],"updated-by":[{"DOI":"10.1186\/s12885-021-08369-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T00:00:00Z","timestamp":1621987200000}}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08019-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-021-08019-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08019-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T23:36:14Z","timestamp":1627688174000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-021-08019-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,8]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["8019"],"URL":"https:\/\/doi.org\/10.1186\/s12885-021-08019-9","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12885-021-08369-4","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,8]]},"assertion":[{"value":"12 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12885-021-08369-4","URL":"https:\/\/doi.org\/10.1186\/s12885-021-08369-4","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our local ethical committee (Manchester University NHS Foundation Trust) stated that as all data were collected as part of the routine clinical record and were compiled retrospectively and anonymously, formal ethical review was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare they have no relevant conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"378"}}